Proportion of isolates with resistance to azithromycin reported to WHO-GASP
Filters
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
Saudi Arabia
Proportion of isolates with resistance to azithromycin reported to WHO-GASP
20172018
Reported azithromycin resistance in gonorrhea by country in 2016 (proportion of isolates with resistance to azithromycin reported to WHO-GASP)
In 2016, Myanmar had the highest value (66.67) among 4 countries, while Kyrgyzstan had the lowest (0).
| # | Country | Value | Change |
|---|---|---|---|
| 1 | Myanmar | 66.67 | – |
| 1 | Croatia (2018) | 60 | +80.2% |
| 1 | Poland (2020) | 34.8 | +324.4% |
| 1 | Estonia (2019) | 25 | – |
| 2 | Mongolia (2020) | 25 | +244.8% |
| 2 | Cyprus (2018) | 20 | – |
Similar Datasets
Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials testing in Neisseria gonorrhoea isolates (WHO-GASP) (number)
WHO (GASP_ISOLATESTESTED_NUMBER)
Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP
WHO (GASPRSCFM)
Proportion of isolates with resistance to ciprofloxacin reported to WHO-GASP
WHO (GASPRSCIP)
Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion)
WHO (GASP_ISOLATESDSR_PROPORTION)